Submit Release

EIN Presswire’s Year-End Special is here: Buy 5 press releases & get 3 FREE—limited time! Start saving today.

World Media Directory · RSS · Email Newsletters

There were 1,446 press releases posted in the last 24 hours and 358,279 in the last 365 days.

Press Releases on April 6, 2014

5 Press Releases

Published on April 6, 2014 - 21:26 GMT

Fusion Health Launches Weight Burn Product to Promote Fat Burning and Weight Loss

BYRON BAY, NSW, AUSTRALIA, April 5, 2014 /EINPresswire.com/ -- Fusion Health has launched their latest product Weight Burn, a high potency standardised green coffee and green tea extract, to assist fat burning and weight loss* in Australia. This month …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on April 6, 2014 - 21:26 GMT

Carrani Tours has teamed up with Gray Line, in an exclusive partnership for tours in Rome.

Gray Line and Carrani Tours, created a partnership that makes Carrani Tours the exclusive operator of all of Gray Line's sightseeing tours in Rome NEW YORK, NEW YORK, UNITED STATES, April 4, 2014 /EINPresswire.com/ -- After meeting at the ITB trade …

Distribution channels: Travel & Tourism Industry
Published on April 6, 2014 - 19:59 GMT

2014 Bahrain Grand Prix – Race

Sakhir - 06 Apr 2014 21:22 UTC MIXED TYRE STRATEGIES AND SAFETY CAR CENTRAL TO LEAD BATTLES PERFORMANCE GAP BETWEEN MEDIUM AND SOFT TYRES DROPS AS TRACK TEMPERATURES FALL DURING THE EVENING RACE FROM TUESDAY, CATERHAM, MERCEDES AND WILLIAMS WILL TEST TYRES …

Distribution channels: Automotive Industry
Published on April 6, 2014 - 15:11 GMT

Early Findings Exploring the Relationship of PD-L1 Expression and Clinical Outcomes with MK-3475, Merck’s Investigational Anti-PD-...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of early findings from studies exploring the relationship between tumor PD-L1 expression and clinical outcomes …

Distribution channels: Companies
Published on April 6, 2014 - 14:46 GMT

Early Findings Exploring the Relationship of PD-L1 Expression and Clinical Outcomes with MK-3475, Merck’s Investigational Anti-PD-...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of early findings from studies exploring the relationship between tumor PD-L1 expression and clinical outcomes …

Distribution channels: Companies